ATP-dependent recruitment, survival and differentiation of dendritic cell precursors in the tumor bed after anticancer chemotherapy

OncoImmunology

Volumn 2, Issue 6, 2013, Pages

  Ma, Yuting ^a,b,c   Adjemian, Sandy ^a,b,c   Yang, Heng ^a,b,c   Catani, João Paulo Portela ^a,b,c   Hannani, Dalil ^b,c,d   Martins, Isabelle ^a,b,c   Michaud, Mickaël ^a,b,c   Kepp, Oliver ^a,b,c   Sukkurwala, Abdul Qader ^a,b,c   Vacchelli, Erika ^a,b,c   Galluzzi, Lorenzo ^b,e   Zitvogel, Laurence ^b,c,d   Kroemer, Guido ^a,b,e,f,g  

^a Institut Gustave Roussy   (France)

^b INSTITUT GUSTAVE ROUSSY   (France)

^c UNIVERSITÉ PARIS SACLAY   (France)

^d INSERM   (France)

^e UNIVERSITÉ PARIS DESCARTES   (France)

^f CENTRE DE RECHERCHE DES CORDELIERS   (France)

^g HÔPITAL EUROPÉEN GEORGES POMPIDOU   (France)

Author keywords

Apoptosis; Autophagy; Calreticulin; CD39; Doxorubicin; Immunogenic cell death

Indexed keywords

ADENOSINE TRIPHOSPHATE; ANTHRACYCLINE; ANTINEOPLASTIC AGENT; CALRETICULIN; CD11B ANTIGEN; CD39 ANTIGEN; GLYCOPROTEIN P 15095;

ADOPTIVE TRANSFER; APOPTOSIS; ARTICLE; CANCER CHEMOTHERAPY; CANCER PROGNOSIS; CANCER RESISTANCE; CELL DIFFERENTIATION; CELL SURVIVAL; CELLULAR DISTRIBUTION; CELLULAR STRESS RESPONSE; CROSS PRESENTATION; DENDRITIC CELL; ENDOPLASMIC RETICULUM STRESS; HUMAN; IMMUNOFLUORESCENCE; INTRACELLULAR SIGNALING; NONHUMAN; PREDICTIVE VALUE; PROTEIN FUNCTION; PROTEIN LOCALIZATION; TUMOR IMMUNITY;

EID: 84886943382     PISSN: 21624011     EISSN: 2162402X     Source Type: Journal    
DOI: 10.4161/onci.24568     Document Type: Article

References (10)

1. Galluzzi L, Senovilla L, Zitvogel L, Kroemer G. The secret ally: immunostimulation by anticancer drugs. Nat Rev Drug Discov 2012; 11:215-33; PMID:22301798; http://dx.doi.org/10.1038/nrd3626
2. Senovilla L, Vacchelli E, Galon J, Adjemian S, Eggermont A, Fridman WH, et al. Trial watch: Prognostic and predictive value of the immune infiltrate in cancer. Oncoimmunology 2012; 1:1323-43; PMID:23243596; http://dx.doi.org/10.4161/onci.22009
3. Kroemer G, Galluzzi L, Kepp O, Zitvogel L. Immunogenic cell death in cancer therapy. Annu Rev Immunol 2013; 31:51-72; PMID:23157435; http://dx.doi.org/10.1146/annurev-immunol- 032712-100008
4. Vacchelli E, Galluzzi L, Fridman WH, Galon J, Sautès-Fridman C, Tartour E, et al. Trial watch: Chemotherapy with immunogenic cell death inducers. Oncoimmunology 2012; 1:179-88; PMID:22720239; http://dx.doi.org/10.4161/onci.1.2.19026
5. Senovilla L, Vitale I, Martins I, Tailler M, Pailleret C, Michaud M, et al. An immunosurveillance mechanism controls cancer cell ploidy. Science 2012; 337:1678-84; PMID:23019653; http://dx.doi.org/10.1126/science. 1224922
6. Martins I, Tesniere A, Kepp O, Michaud M, Schlemmer F, Senovilla L, et al. Chemotherapy induces ATP release from tumor cells. Cell Cycle 2009; 8:3723-8; PMID:19855167; http://dx.doi.org/10.4161/cc.8.22.10026
7. Michaud M, Martins I, Sukkurwala AQ, Adjemian S, Ma Y, Pellegatti P, et al. Autophagy-dependent anticancer immune responses induced by chemotherapeutic agents in mice. Science 2011; 334:1573-7; PMID:22174255; http://dx.doi.org/10.1126/science. 1208347
8. Michaud M, Sukkurwala AQ, Martins I, Shen S, Zitvogel L, Kroemer G. Subversion of the chemotherapy- induced anticancer immune response by the ecto-ATPase CD39. Oncoimmunology 2012; 1:393-5; PMID:22737627; http://dx.doi.org/10.4161/onci.19070
9. Ma Y, Aymeric L, Locher C, Mattarollo SR, Delahaye NF, Pereira P, et al. Contribution of IL-17-producing gamma delta T cells to the efficacy of anticancer chemotherapy. J Exp Med 2011; 208:491-503; PMID:21383056; http://dx.doi.org/10.1084/jem.20100269
10. Ma Y, Adjemian S, Mattarollo SR, Yamazaki T, Aymeric L, Yang H, et al. Anticancer chemotherapyinduced intratumoral recruitment and differentiation of antigen-presenting cells. Immunity 2013; In press; PMID:23562161; http://dx.doi.org/10.1016/j.immuni. 2013.03.003